These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23177744)

  • 1. Vocal changes in patients with prostate cancer following androgen ablation.
    Hamdan AL; Jabbour J; Saadeh R; Kazan I; Nassar J; Bulbul M
    J Voice; 2012 Nov; 26(6):812.e11-5. PubMed ID: 23177744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate post-operative vocal changes in patients using laryngeal mask airway versus endotracheal tube.
    Hamdan AL; Kanazi G; Rameh C; Rifai H; Sibai A
    J Laryngol Otol; 2008 Aug; 122(8):829-35. PubMed ID: 17617935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective and Objective Effects of Androgen Ablation Therapy on Voice.
    Salturk Z; Çakır O; Kumral TL; Yıldırım G; Ötünçtemur A; Aydoğdu Ï; Uyar Y
    J Voice; 2015 Jul; 29(4):490-3. PubMed ID: 25704476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pregnancy on the speaking voice.
    Hamdan AL; Mahfoud L; Sibai A; Seoud M
    J Voice; 2009 Jul; 23(4):490-3. PubMed ID: 18346868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vocal changes in patients using nasal continuous positive airway pressure.
    Hamdan AL; Sabra O; Rifai H; Tabri D; Hussari A
    J Voice; 2008 Sep; 22(5):603-6. PubMed ID: 18762134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of endotracheal intubation on voice.
    Hamdan AL; Sibai A; Rameh C; Kanazeh G
    J Voice; 2007 Nov; 21(6):762-8. PubMed ID: 16905292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report in changes in phonatory physiology following voice therapy: application of high-speed imaging.
    Patel RR; Pickering J; Stemple J; Donohue KD
    J Voice; 2012 Nov; 26(6):734-41. PubMed ID: 22717492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
    Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
    J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voice change in end-stage renal disease patients after hemodialysis: correlation of subjective hoarseness and objective acoustic parameters.
    Jung SY; Ryu JH; Park HS; Chung SM; Ryu DR; Kim HS
    J Voice; 2014 Mar; 28(2):226-30. PubMed ID: 24275458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis and fractures after androgen deprivation initiation for prostate cancer.
    Malcolm JB; Derweesh IH; Kincade MC; DiBlasio CJ; Lamar KD; Wake RW; Patterson AL
    Can J Urol; 2007 Jun; 14(3):3551-9. PubMed ID: 17594745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
    Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voice outcome in patients treated for laryngeal cancer: efficacy of voice rehabilitation.
    Tuomi L; Björkner E; Finizia C
    J Voice; 2014 Jan; 28(1):62-8. PubMed ID: 23769005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of weight loss on voice after bariatric surgery.
    Hamdan AL; Safadi B; Chamseddine G; Kasty M; Turfe ZA; Ziade G
    J Voice; 2014 Sep; 28(5):618-23. PubMed ID: 24954040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset psychosis following androgen deprivation therapy for prostate cancer.
    Bernad DM; Dal Pra A; Baule C; Frey BN; Faria S
    Can J Urol; 2013 Aug; 20(4):6868-70. PubMed ID: 23930615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer.
    Soga N; Hori Y; Ogura Y; Hayashi N; Sugimura Y
    Jpn J Clin Oncol; 2012 Jun; 42(6):534-40. PubMed ID: 22438406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?
    Perachino M; Cavalli V; Bravi F
    BJU Int; 2010 Mar; 105(5):648-51. PubMed ID: 19747358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of hemodialysis on voice: an acoustic analysis.
    Hamdan AL; Medawar W; Younes A; Bikhazi H; Fuleihan N
    J Voice; 2005 Jun; 19(2):290-5. PubMed ID: 15907443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
    DiBlasio CJ; Malcolm JB; Hammett J; Wan JY; Aleman MA; Patterson AL; Wake RW; Derweesh IH
    BJU Int; 2009 Nov; 104(9):1208-14. PubMed ID: 19388987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.